Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Belgium Czechia Finland Germany Hungary +3
  • Study of BLU-451 for Patients with Advanced Cancers Having EGFR Exon20 Insertion Mutations

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study of S095035 and TNG462 in adults with advanced or metastatic solid tumors with MTAP deletion

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark France Germany Italy Spain
  • Study of PRT3789 and Pembrolizumab for Patients with Advanced Solid Tumors, Esophageal Cancer, or NSCLC with SMARCA4 Mutation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Spain
  • Study on the Safety and Effectiveness of GEN1078 for Patients with Malignant Solid Tumors

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Spain
  • Study on Methadone Hydrochloride and Drug Combination for Patients with Advanced Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Germany
  • Study on JAB-21822 for Adults with Advanced Solid Tumors with KRAS G12C Mutation

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Safety Study of GEN1046 and Pembrolizumab in Patients with Malignant Solid Tumors

    Not recruiting

    2 1 1 1
    Hungary Italy Poland Spain
  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1 1
    Investigated Drugs:
    Spain
  • Study on the Safety of Avelumab, Lorlatinib, and Axitinib for Cancer Patients Continuing from Previous Trials

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Denmark France Hungary Italy Poland +1